Opinion
Volume 14 Issue 8 - 2018
Pharmaceuticals and Intracellular Bacteria
Abbas Alnaji*
Consultant Neurosurgeon, Alsadir Medical City, Najaf, Iraq
*Corresponding Author: Abbas Alnaji, Consultant Neurosurgeon, Alsadir Medical City, Najaf, Iraq.
Received: May 24, 2018; Published: July 30, 2018
Citation: Abbas Alnaji. “Pharmaceuticals and Intracellular Bacteria”. EC Microbiology 14.8 (2018): 494-496.
Abstract
Some fifteen intracellular bacteria ICB could be identified harboring the human living cell may be for the rest of its (the cell) life with all slow ongoing structural changes that end with many varieties of diseases the more importantly the chronic ones. Chemotherapy against these intracellular bacteria is ineffective and poorly understood. So, Eradication practically is not a fact. A shed of light should be thrown by someone to alarm and notify the health community for the potential hazards and to the role of the intracellular bacteria in particular in pathogenesis of un-known etiology health castrophies. Also what should be managed to combat these ICB.
Keywords: Intracellular Bacteria; Therapeutics; Neuron; Pharmaceuticals; Sick Cell; Brucella; Salmonella; Carcinogenesis bacteriophage
Copyright: © 2018 Abbas Alnaji. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

News and Events

Welcoming Article Submission

ECronicon delightfully welcomes the authors for submission of articles towards the upcoming issue of respective journals.

Submission Timeline

Last date for submission of articles is November 01, 2018.

Publication Certificate

Authors will be issued a "Publication Certificate" as a token of appreciation for publishing their work.

Best Article of the Issue

The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue".

Share this article

Visitors: 3115398